display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
muscular invasive bladder cancer (MIBC)
MIBC - NA - PDL1 positive
immune chekpoint inhibitors
anti-PD-(L)1
nivolumab based treatment
nivolumab alone CheckMate 274 ...

Study type: